Literature DB >> 7503758

4-Ipomeanol and 2-aminoanthracene cytotoxicity in C3H/10T1/2 cells expressing rabbit cytochrome P450 4B1.

P B Smith1, H F Tiano, S Nesnow, M R Boyd, R M Philpot, R Langenbach.   

Abstract

In the present study, retroviral vectors were used to stably transfer and express the cDNA encoding rabbit CYP4B1 in mouse C3H/10T1/2 cells. The replication defective retroviral vector was packaged in the ecotropic packaging cell line, GP+E-86, with infectious titer of approximately 1 x 10(6) cfu/mL. Infection, followed by selection with G418, showed an infection efficiency of approximately 70% for the recipient C3H/10T1/2 cells. Analysis of ten G418 resistant clones showed that the number of vector inserts ranged from 4 to 13 copies per cell genome. Each clone was positive for microsomal CYP4B1 protein as determined by immunoblotting. Cytochrome P450 4B1 activity was assessed by the cytotoxicity of 4-ipomeanol, a known substrate for P450 4B1 and a model compound for chemical-induced injury to the lung. The initial clonigenic assays showed that 100% toxicity occurred in all the clones after a 96-hr exposure to 250 microM 4-ipomeanol. Parental C3H/10T1/2 cells were resistant to 4-ipomeanol at concentrations as high as 1 mM. Two clones, designated No. 2 and No. 19, differing in levels of P450 4B1 protein, were characterized further for 4-ipomeanol and other chemical toxicities. A concentration-response study indicated 50% cytotoxicity at 4-ipomeanol concentrations of 1.5 micrograms/mL for clone No. 2 and 2.5 micrograms/mL for clone No. 19. A panel of agents representing the aromatic amines, some of which are known or suspected P450 4B1 substrates, were tested for cytotoxicity in clone No. 2. These agents included 2-aminoanthracene, 2-aminonaphthalene, 2-aminofluorene, 2-acetylaminofluorene and 4-aminobiphenyl. Only 2-aminoanthracene gave a clear cytotoxic response reducing the survival fraction of clone No. 2 to 50% at 0.2 micrograms/mL while affecting parental cells minimally. In vitro expression of CYP4B1 provides a new experimental system for further elucidating the cytotoxic and mutagenic effects of P450 4B1 substrates.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7503758     DOI: 10.1016/0006-2952(95)02029-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  Influence of Stereochemistry on the Bioactivation and Glucuronidation of 4-Ipomeanol.

Authors:  Aaron M Teitelbaum; Matthew G McDonald; John P Kowalski; Oliver T Parkinson; Michele Scian; Dale Whittington; Katharina Roellecke; Helmut Hanenberg; Constanze Wiek; Allan E Rettie
Journal:  J Pharmacol Exp Ther       Date:  2018-11-08       Impact factor: 4.030

2.  Ligand characterization of CYP4B1 isoforms modified for high-level expression in Escherichia coli and HepG2 cells.

Authors:  Katharina Roellecke; Vera D Jäger; Veselin H Gyurov; John P Kowalski; Stephanie Mielke; Allan E Rettie; Helmut Hanenberg; Constanze Wiek; Marco Girhard
Journal:  Protein Eng Des Sel       Date:  2017-03-01       Impact factor: 1.650

3.  Novel insights into oxidation of fatty acids and fatty alcohols by cytochrome P450 monooxygenase CYP4B1.

Authors:  Florian A Thesseling; Michael C Hutter; Constanze Wiek; John P Kowalski; Allan E Rettie; Marco Girhard
Journal:  Arch Biochem Biophys       Date:  2019-12-01       Impact factor: 4.013

4.  Synthesis and evaluation of a 18F-labeled 4-ipomeanol as an imaging agent for CYP4B1 gene prodrug activation therapy.

Authors:  Byung Seok Moon; Su Jin Jang; Sung Joo Kim; Tae Sup Lee; Dae Yoon Chi; Byung Chul Lee; Joo Hyun Kang; Sang Eun Kim
Journal:  Cancer Biother Radiopharm       Date:  2013-05-19       Impact factor: 3.099

5.  Prodrug-activating Gene Therapy with Rabbit Cytochrome P450 4B1/4-Ipomeanol or 2-Aminoanthracene System in Glioma Cells.

Authors:  Su Jin Jang; Joo Hyun Kang; Tae Sup Lee; Sung Joo Kim; Kwang Il Kim; Yong Jin Lee; Gi Jeong Cheon; Chang Woon Choi; Sang Moo Lim
Journal:  Nucl Med Mol Imaging       Date:  2010-08-07

6.  Characterization of an Additional Splice Acceptor Site Introduced into CYP4B1 in Hominoidae during Evolution.

Authors:  Eva M Schmidt; Constanze Wiek; Oliver T Parkinson; Katharina Roellecke; Marcel Freund; Michael Gombert; Nadine Lottmann; Charles A Steward; Christof M Kramm; Vladimir Yarov-Yarovoy; Allan E Rettie; Helmut Hanenberg
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.